City of Hope, Eli Lilly partner on residency program

Duarte, Calif.-based City of Hope and Eli Lilly have partnered on an oncology-based pharmacy residency program.

Wafa Samara, PharmD, vice president and chief pharmacy officer at City of Hope, shared news of the partnership in a Dec. 29 LinkedIn post.

The post-graduate, year-two residency aims to “develop highly skilled oncology pharmacists” to strengthen the healthcare workforce and improve patient outcomes, Dr. Samara said in the post.

Next Up in Pharmacy

Specialty drugs surpass 50% of pharma sales

Specialty medications, which can cost between $10,000 and upward of $5 million, now account for 52% of U.S. pharmaceutical sales,…

75 drugs currently in shortage: FDA

The number of active drug shortages has declined sharply since June, according to the FDA’s drug shortage database. Seventy-five drugs…

6 recent updates on GLP-1 drugs

From payer shifts to regulatory milestones, GLP-1 therapies for obesity and diabetes continued to reshape the healthcare landscape in December.…

The critical balance: How hospital medicine aligns patient acuity and system capacity to protect access to care

Next Up in Pharmacy

Specialty drugs surpass 50% of pharma sales

75 drugs currently in shortage: FDA

6 recent updates on GLP-1 drugs

Join the 500,000+ healthcare executives who start their day with Becker’s